Severin Schwan - Roche Holding CEO Director

RHO6 Stock  EUR 34.08  0.08  0.24%   

Insider

Severin Schwan is CEO Director of Roche Holding Ltd
Age 56
Phone41 61 688 11 11
Webhttps://www.roche.com

Roche Holding Management Efficiency

The company has return on total asset (ROA) of 0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Roche Holding Ltd has accumulated 16.08 B in total debt with debt to equity ratio (D/E) of 0.39, which is about average as compared to similar companies. Roche Holding has a current ratio of 1.27, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Roche Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Roche Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Roche Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Roche to invest in growth at high rates of return. When we think about Roche Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Bo NiuTianjin Capital Environmental
46
Jan HarritPARKEN Sport Entertainment
58
Mingwei ZhaoTianjin Capital Environmental
42
Yi ZhaoTianjin Capital Environmental
52
Yuji NoguchiDaido Steel Co
N/A
Wanying JingTianjin Capital Environmental
46
Takeshi IshiguroDaido Steel Co
66
Yuji KamiyaDaido Steel Co
N/A
Lipin QiTianjin Capital Environmental
46
Jinhe LiTianjin Capital Environmental
52
Jian ZhangTianjin Capital Environmental
65
Takaaki TaketsuruDaido Steel Co
N/A
Toshiaki YamashitaDaido Steel Co
59
Tetsuya ShimizuDaido Steel Co
61
Tsukasa NishimuraDaido Steel Co
66
Yujun LiuTianjin Capital Environmental
57
Kazuhiro ToshimitsuDaido Steel Co
61
Jing WangTianjin Capital Environmental
52
Yang LiTianjin Capital Environmental
54
Tadashi ShimaoDaido Steel Co
73
Akihito KajitaDaido Steel Co
61
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101465 people. Roche Holding Ltd (RHO6) is traded on Frankfurt Exchange in Germany and employs 103,613 people.

Management Performance

Roche Holding Leadership Team

Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Claudia Bockstiegel, G Counsel
Barbara Schadler, Head Communications
Johannes MD, Head Devel
Bruno Eschli, Head Relations
Thomas Schinecker, Chief Diagnostics
Cristina Wilbur, Chief Officer
William Anderson, Chief Pharmaceuticals
Alan Hippe, Chief Officer
Severin Schwan, CEO Director
Pascale Schmidt, Chief Officer

Roche Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roche Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Roche Stock

Roche Holding financial ratios help investors to determine whether Roche Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Holding security.